Menu
GeneBe

RAB7A

RAB7A, member RAS oncogene family, the group of RAB, member RAS oncogene GTPases

Basic information

Region (hg38): 3:128693668-128825942

Previous symbols: [ "RAB7", "CMT2B" ]

Links

ENSG00000075785NCBI:7879OMIM:602298HGNC:9788Uniprot:P51149AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

  • Charcot-Marie-Tooth disease type 2B (Strong), mode of inheritance: AD
  • Charcot-Marie-Tooth disease type 2B (Supportive), mode of inheritance: AD
  • Charcot-Marie-Tooth disease type 2 (Definitive), mode of inheritance: AD

Clinical Genomic Database

Source: CGD

ConditionInheritanceIntervention CategoriesIntervention/Rationale Manifestation CategoriesReferences
Charcot-Marie-Tooth disease, axonal, type 2BADGeneralGenetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testingNeurologic7573046; 9219740; 11094113; 12545426; 17060578; 22302274

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the RAB7A gene.

  • Charcot-Marie-Tooth disease type 2B (134 variants)
  • not provided (42 variants)
  • Inborn genetic diseases (14 variants)
  • Charcot-Marie-Tooth disease (13 variants)
  • not specified (9 variants)
  • Charcot-Marie-Tooth disease type 2 (6 variants)

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the RAB7A gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
25
clinvar
1
clinvar
26
missense
4
clinvar
32
clinvar
3
clinvar
39
nonsense
0
start loss
0
frameshift
0
inframe indel
0
splice donor/acceptor (+/-2bp)
0
splice region
3
8
1
12
non coding
31
clinvar
34
clinvar
19
clinvar
84
Total 4 0 63 62 20

Variants in RAB7A

This is a list of pathogenic ClinVar variants found in the RAB7A region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
3-128726153-C-T Charcot-Marie-Tooth disease type 2B Benign (Jan 13, 2018)343150
3-128726153-C-CGGCGGT Charcot-Marie-Tooth disease type 2 Conflicting classifications of pathogenicity (Sep 01, 2022)343149
3-128726164-G-T Charcot-Marie-Tooth disease type 2B Uncertain significance (Jan 13, 2018)343151
3-128726214-G-A Charcot-Marie-Tooth disease type 2B Uncertain significance (Jan 12, 2018)343152
3-128726222-G-C Charcot-Marie-Tooth disease type 2B Uncertain significance (Jan 13, 2018)899873
3-128726253-C-T Charcot-Marie-Tooth disease type 2B Benign (Jan 13, 2018)343153
3-128726271-C-G Charcot-Marie-Tooth disease type 2B Benign/Likely benign (Nov 18, 2020)343154
3-128726297-TCTC-T Charcot-Marie-Tooth disease type 2 Conflicting classifications of pathogenicity (Sep 01, 2022)343155
3-128726307-G-A Charcot-Marie-Tooth disease type 2B Uncertain significance (Jan 12, 2018)899874
3-128726339-G-T not specified • Charcot-Marie-Tooth disease type 2B Benign (Jan 13, 2018)138862
3-128726350-A-G Charcot-Marie-Tooth disease type 2B • not specified • RAB7A-related disorder Conflicting classifications of pathogenicity (Jul 26, 2022)343156
3-128726387-G-T Likely benign (Oct 27, 2021)1683833
3-128726579-G-T Likely benign (Jan 20, 2021)1254709
3-128795080-A-G Benign (Jun 19, 2018)671681
3-128795218-T-G Benign (Jun 19, 2018)674517
3-128795348-T-C not specified Likely benign (Dec 31, 2015)382633
3-128795362-T-C not specified Likely benign (May 27, 2016)386584
3-128795373-C-G Charcot-Marie-Tooth disease type 2B Likely benign (Jun 19, 2022)701678
3-128795385-A-G Charcot-Marie-Tooth disease type 2B Likely benign (Jul 30, 2020)1126484
3-128795388-G-A Charcot-Marie-Tooth disease type 2B • Charcot-Marie-Tooth disease • Inborn genetic diseases • RAB7A-related disorder Likely benign (Dec 05, 2023)464094
3-128795427-T-C Charcot-Marie-Tooth disease type 2B Likely benign (Aug 08, 2020)1110069
3-128795429-C-G Charcot-Marie-Tooth disease type 2B Likely benign (Jun 20, 2023)2910345
3-128795434-G-T Charcot-Marie-Tooth disease type 2B Likely benign (Dec 18, 2023)2185840
3-128795495-G-A Likely benign (Aug 03, 2018)1211274
3-128795653-T-C Likely benign (Jun 16, 2018)678234

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
RAB7Aprotein_codingprotein_codingENST00000265062 588675
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
0.9690.030600000.00
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense2.28461150.4010.000006751375
Missense in Polyphen135.5110.02816440
Synonymous0.2964143.50.9430.00000254378
Loss of Function3.04010.80.005.53e-7121

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.000.00
Ashkenazi Jewish0.000.00
East Asian0.000.00
Finnish0.000.00
European (Non-Finnish)0.000.00
Middle Eastern0.000.00
South Asian0.000.00
Other0.000.00

dbNSFP

Source: dbNSFP

Function
FUNCTION: Key regulator in endo-lysosomal trafficking. Governs early-to-late endosomal maturation, microtubule minus-end as well as plus-end directed endosomal migration and positioning, and endosome-lysosome transport through different protein-protein interaction cascades. Plays a central role, not only in endosomal traffic, but also in many other cellular and physiological events, such as growth-factor-mediated cell signaling, nutrient- transportor mediated nutrient uptake, neurotrophin transport in the axons of neurons and lipid metabolism. Also involved in regulation of some specialized endosomal membrane trafficking, such as maturation of melanosomes, pathogen-induced phagosomes (or vacuoles) and autophagosomes. Plays a role in the maturation and acidification of phagosomes that engulf pathogens, such as S.aureus and M.tuberculosis. Plays a role in the fusion of phagosomes with lysosomes. Plays important roles in microbial pathogen infection and survival, as well as in participating in the life cycle of viruses. Microbial pathogens possess survival strategies governed by RAB7A, sometimes by employing RAB7A function (e.g. Salmonella) and sometimes by excluding RAB7A function (e.g. Mycobacterium). In concert with RAC1, plays a role in regulating the formation of RBs (ruffled borders) in osteoclasts. Controls the endosomal trafficking and neurite outgrowth signaling of NTRK1/TRKA (PubMed:11179213, PubMed:12944476, PubMed:14617358, PubMed:20028791, PubMed:21255211). Regulates the endocytic trafficking of the EGF- EGFR complex by regulating its lysosomal degradation. Involved in the ADRB2-stimulated lipolysis through lipophagy, a cytosolic lipase-independent autophagic pathway (By similarity). Required for the exosomal release of SDCBP, CD63 and syndecan (PubMed:22660413). {ECO:0000250|UniProtKB:P51150, ECO:0000269|PubMed:11179213, ECO:0000269|PubMed:12944476, ECO:0000269|PubMed:14617358, ECO:0000269|PubMed:20028791, ECO:0000269|PubMed:22660413}.;
Pathway
Salmonella infection - Homo sapiens (human);Endocytosis - Homo sapiens (human);Phagosome - Homo sapiens (human);Autophagy - animal - Homo sapiens (human);Amoebiasis - Homo sapiens (human);Mitophagy - animal - Homo sapiens (human);Tuberculosis - Homo sapiens (human);Ebola Virus Pathway on Host;Ebola Virus Pathway on Host;Neutrophil degranulation;Vesicle-mediated transport;TBC/RABGAPs;Membrane Trafficking;Post-translational protein modification;Metabolism of proteins;Innate Immune System;Immune System;Rab regulation of trafficking;Posttranslational regulation of adherens junction stability and dissassembly;RAB GEFs exchange GTP for GDP on RABs;RAB geranylgeranylation;IL8- and CXCR2-mediated signaling events;IL12-mediated signaling events (Consensus)

Intolerance Scores

loftool
rvis_EVS
-0.23
rvis_percentile_EVS
36.86

Haploinsufficiency Scores

pHI
0.503
hipred
Y
hipred_score
0.783
ghis
0.623

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
S
essential_gene_gene_trap
N
gene_indispensability_pred
E
gene_indispensability_score
0.945

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumLowMedium
Primary ImmunodeficiencyMediumLowMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Rab7
Phenotype
mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); normal phenotype; hematopoietic system phenotype; embryo phenotype; immune system phenotype; cellular phenotype;

Gene ontology

Biological process
autophagosome assembly;protein targeting to lysosome;intracellular protein transport;endocytosis;epidermal growth factor catabolic process;endosome to lysosome transport;protein transport;lipid catabolic process;viral release from host cell;antigen processing and presentation of exogenous peptide antigen via MHC class II;protein to membrane docking;Rab protein signal transduction;retrograde transport, endosome to Golgi;neutrophil degranulation;early endosome to late endosome transport;positive regulation of protein catabolic process;positive regulation of viral process;lipophagy;phagosome maturation;phagosome acidification;phagosome-lysosome fusion;multi-organism intracellular transport;negative regulation of exosomal secretion;positive regulation of exosomal secretion;negative regulation of intralumenal vesicle formation
Cellular component
autophagosome membrane;lysosome;lysosomal membrane;late endosome;vacuolar membrane;Golgi apparatus;lipid droplet;cytosol;plasma membrane;endosome membrane;secretory granule membrane;phagocytic vesicle membrane;retromer complex;late endosome membrane;extrinsic component of lysosome membrane;melanosome membrane;phagophore assembly site membrane;phagocytic vesicle;extracellular exosome
Molecular function
GTPase activity;protein binding;GTP binding;GDP binding;retromer complex binding